Skip to main content
. 2022 Nov 19;13:127. doi: 10.1007/s12672-022-00586-y

Fig. 2.

Fig. 2

The Kaplan–Meier survival analysis of non-squamous non-small cell lung cancer patients with different Beclin 1 level, EGFR and ALK mutations